MBX Biosciences
MBX----
Q1 FY2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Preview: MBX Biosciences(MBX) predict that the EBIT is -27.33 M (-3%), Beat estimate;the EPS is -0.51 (+28.17%), Beat estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
TBA--
0.00B--
----
EBITExceed expectations
-0.03B3.00%
-0.03B14.44%
+0.00B11.44%
EPSExceed expectations
-0.5128.17%
-0.584817.64%
+0.074810.53%
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf